MustGrow to Attend 10th Annual Whistler Capital Conference
06 Février 2020 - 1:00PM
MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF)
(the "
Company", "
MustGrow"), an
agricultural biotech company developing and commercializing a
portfolio of natural, science-based biological crop protection
products, will be attending the 10th Annual Whistler Capital
Conference, hosted by Capital Event Conferences, taking place
Friday February 7th through Sunday February 9th at the Fairmont
Chateau Whistler. The conference introduces growth-stage companies
(Resource, Technology, Biotech, Special Situations) to active
top-level capital finance individuals through a weekend of
scheduled one-on-one meetings.
MustGrow is excited to introduce to prospective
investors its patented natural biological approach to crop
protection. MustGrow’s signature bio-pesticide products are derived
from mustard seed, utilizing the plant’s natural defense mechanism
as a pre-plant soil treatment. Organic compounds found in mustard
seed, combined with water, form allyl isothiocyanate (AITC), which
is the active ingredient. MustGrow has concentrated the active
ingredient in both granular and liquid format to maximize safety
and efficacy. MustGrow’s granular product is EPA-approved across
all key U.S. states as a bio-pesticide (currently limited to a
bio-fertilizer in California) and is designated by Health Canada’s
PMRA (Pest Management Regulatory Agency) as a fruit, vegetable,
turf and ornamental bio-pesticide.
MustGrow’s signature mustard-derived products
have consistently demonstrated efficacious benefits similar to
chemistry-based "chemical" products without the harmful safety
profile often associated with these chemical products. The need for
bio-pesticides and bio-herbicides is increasing as farmers,
consumers and regulators seek alternatives to synthetic chemical
pesticides. The dangers associated with synthetic chemical overuse
is pushing these groups to naturally-sourced biological products,
such as MustGrow’s mustard-derived products, which are known for
safe, environmentally-sustainable and consumer-friendly profile
characteristics.
MustGrow’s intellectual property suite is a
platform for several crop protection categories, aiming to disrupt
global agriculture markets that have traditionally been dominated
by chemistry-based products. MustGrow’s existing patent portfolio
protects both method-of-use and composition-of-matter claims for
MustGrow’s signature mustard-derived approach to controlling
unwanted pests, diseases, and weeds.
About MustGrow
MustGrow is a publicly traded (CSE:
MGRO) (OTC: MGROF) agricultural biotech company focused on
providing natural science-based biological solutions for high value
crops, including fruit & vegetable and cannabis cultivation.
MustGrow has designed and owns a United States EPA-approved organic
solution that uses the mustard seed’s natural defence mechanism to
protect plants from pests and diseases. 110 independent tests have
been completed, validating MustGrow’s safe and effective signature
products. This product, in granule format, is EPA-approved across
all key U.S. states as a bio-fertilizer and bio-pesticide
(currently limited to a bio-fertilizer in California) and is
designated by Health Canada’s PMRA (Pest Management Regulatory
Agency) as a fruit & vegetable bio-pesticide and
bio-fertilizer. MustGrow has now concentrated a liquid format to be
applied through standard drip or spray equipment, improving
functionality and performance features.
In cannabis, MustGrow is currently developing
effective, safe and biological solutions that adhere to Health
Canada’s strict regulations, including (1) its mustard-derived
bio-pesticide to treat soil-borne pests and diseases; and (2) an
in-licensed bio-fungicide for powdery mildew.
The Company has approximately 36.4 million basic
common shares issued and outstanding. For further details please
visit www.mustgrow.ca.
ON BEHALF OF THE BOARD
"Corey Giasson"
Director & CEO Phone: +1-306-668-2652
Forward-Looking Statements
Certain statements included in this press
release constitute "forward-looking statements" which involve known
and unknown risks, uncertainties and other factors that may affect
the results, performance or achievements of MustGrow.
Generally, forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects", "is expected", "budget", "estimates",
"intends", "anticipates" or "does not anticipate", or "believes",
or variations of such words and phrases or statements that certain
actions, events or results "may", "could", "would", "might",
"occur" or "be achieved".
Forward-looking statements are subject to a
number of risks and uncertainties that may cause the actual results
of MustGrow to differ materially from those discussed in such
forward-looking statements, and even if such actual results are
realized or substantially realized, there can be no assurance that
they will have the expected consequences to, or effects on,
MustGrow.
These risks are described in more detail in
MustGrow’s Prospectus and other continuous disclosure documents
filed by MustGrow with the applicable securities regulatory
authorities and available at www.sedar.com. Readers are
referred to such documents for more detailed information about
MustGrow, which is subject to the qualifications, assumptions and
notes set forth therein.
This release does not constitute an offer for
sale of, nor a solicitation for offers to buy, any securities in
the United States. Neither the CSE nor its Regulation Services
Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this
release.
Important
Always read and follow label use directions. ©
2019 MustGrow Biologics Corp. All rights reserved.
MustGrow Biologics (CSE:MGRO)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
MustGrow Biologics (CSE:MGRO)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024